Human African trypanosomiasis (HAT), also known as sleeping sickness, is a neglected disease that impacts 70 million people distributed over 1.55 million km² in sub-Saharan Africa [1]. Trypanosoma brucei gambiense accounts for almost 90% of the infections in central and western Africa, the remaining infections being from T. b. rhodesiense in eastern Africa [1]. Furthermore, the animal diseases caused by related parasites inflict major economic losses to countries already strained [2]. The parasites are transmitted to the mammalian hosts through the bite of an infected tsetse fly.

In the early part of the 20th century, HAT epidemics decimated human populations in many parts of Africa. In the 1930s, systematic screening, treatment, and follow-up of millions of individuals by the colonial administrations led to a dramatic decrease in disease transmission (reviewed in [3]). Following independence in the 1950–60s, HAT control efforts in most African countries were relaxed and taken over by other priorities in light of the decline in disease incidence. Unfortunately, the disease slowly returned, with flare-ups beginning to be reported throughout the endemic areas by the late 80s and early 90s [4], [5], [6]. In a 1997 resolution, WHO strongly advocated access to diagnosis and treatment with surveillance and control activities, concurrently setting up a network to strengthen coordination among endemic countries [7], [8]. Sadly, the disease killed thousands of people before control measures began to take effect [9]. In 2006, 20 out of the 36 endemic countries had achieved the target of no new cases, and eight countries reported fewer than 100 cases. In 2008, WHO declared that the newly reported cases had dramatically declined to fewer than 10,000 continent-wide and called for plans towards a HAT elimination policy [10]. The gambiense form of the disease has been targeted for elimination by 2020 [11]. It is important to note, however, that estimating the true burden of HAT is difficult, as the disease affects the most neglected populations, living in remote and rural settings where the majority of people affected are beyond the reach of health care systems and are not reported in the health metrics [12]. It is also important to be mindful of ongoing political conflicts, which stand to refuel the emergence of epidemics unless control measures continue to be employed in endemic countries [13], [14], [15]. Thus, it is imperative that endemic countries must at least continue to retain mechanisms and health personnel who can recognize and report potential HAT cases to prevent reemergence of the disease [16]. A flexible set of control efforts needs to be adapted to the different epidemiological patterns in order to adopt the most adequate strategies for maintaining cost-effectiveness [17], [18].

Achieving disease control in the mammalian host has been challenging given the lack of effective mammalian vaccines and cheap and easily deliverable drugs. Furthermore, at times of low endemicity, relying on active surveillance of human infections is not cost-effective. The challenge now is to identify control methods that will ensure that the continent remains free of HAT. One approach that has worked well to curb disease is the reduction of tsetse vector populations. This is due to the low reproductive rate of tsetse resulting from its viviparous biology. Improving the efficacy of the currently available vector control tools (targets, traps, and insecticide applications) or enhancing the implementation of control programs that utilize this set of tools in different ecological settings can improve effectiveness. Also, the effectiveness of these tools can be improved through a better understanding of tsetse physiology—a feature that has enabled the development of these tools in the first place. The complete genome sequence information from Glossina morsitans morsitans, published in Science this week, now provides a unique opportunity to transform tsetse research and disease control practices [19]. Particularly important in this regard is knowledge of tsetse's vision, olfactory, immune, digestive and reproductive physiology. The eight research papers published this week PLOS-wide that accompany the tsetse genome paper already point to unique opportunities for improving control (see Tsetse Genome Biology Collection).

Getting at the genome data, however, has not been an easy road. The Glossina community was small, and many of the facilities in Africa that maintained tsetse fly colonies and conducted research on this vector were beginning to downsize their programs in the early 2000s due to reduced research funds, despite the rising disease incidence. A small group of researchers, however, argued that moving tsetse research into the -omics era would provide new stimulus that would give rise to opportunities for control and, importantly, would attract young researchers to the field of tsetse research [20]. The Molecular Entomology work area of the Special Programme for Research and Training in Tropical Diseases (TDR) at the World Health Organization (WHO) funded the establishment of a consortium (International Glossina Genome Initiative [IGGI]) in 2004 that brought together an interdisciplinary group of researchers from multiple institutions to chart the course towards the finish line [20], [21]. The consortium recruited global funds that enabled the development of a molecular toolbox, which initially included data from several large expressed-sequence (EST) libraries along with construction and sequencing of a Bacterial Artificial Chromosome (BAC) library. Given that the tsetse vector and the disease is endemic to sub-Sahara Africa, IGGI membership chose to use this networking opportunity to help build research capacity in Africa on genetics and genomics aspects of tsetse [21]. In the following seven years, the IGGI consortium met yearly for coordination meetings, organized five bioinformatics workshops that trained students and junior faculty from endemic countries, and set up exchange programs for students and researchers from Africa to be trained in research laboratories in Europe and the United States. Over 40 African students and researchers from African institutions attended a transcriptome analysis jamboree held at the South African National Bioinformatics Institute (SANBI) in 2007. The genome project led by the Sanger Institute also benefited from the contributions of many genome centers, including TIGR in the US, RIKEN in Japan, and Genoscope in France. Two manual community annotation workshops and the 146 experts recruited from the broad vector community helped the program to reach the finish line this month. Building on their success story with Glossina morsitans genome, the consortium has now secured funds from the National Institute of Health in the US to sequence five additional species of Glossina at the University of Washington Genome Center, and this project is nearly complete.

The PLOS-wide collection, titled Tsetse Genome Biology, accompanying this issue presents two Historical Perspective articles that review events related to the devastating HAT epidemics in the early years of the 20th century [22], [23]. In addition, the collection has eight research articles that expand on the genome discoveries and report on several low hanging fruits that are ready for exploitation for improved vector control. One of these discoveries is related to the tsetse olfactory system, which appears to be significantly streamlined when compared to other disease vectors, such as mosquitoes [24]. At the core of the success of the trapping devices is the ability of tsetse to recognize the color blue and be attracted to certain smells, which are used as bait. The availability of the full spectrum of olfactory components now stands to provide new or more effective species-specific attractants that can improve the efficacy of traps. Another area that is unique among disease vectors is tsetse's viviparous reproductive system, which involves the production of one progeny at a time that is nourished by the milk secretions of the mother during intrauterine development. Each female can produce on average eight to ten progeny, and she remains fecund during much of her adult life. This low reproductive capacity is at the core of the success of strategies that aim to reduce tsetse populations. To nurture its developing larva, the tsetse female lactates and produces milk. Researchers have now identified a previously unknown group of indispensable milk proteins that are coordinately synthesized during the lactation phase. Without these proteins, the female cannot support her developing larva [25]. Interestingly, a single transcription factor, the homeobox factor Ladybird Late, may be responsible for the coordinated expression of all milk proteins, opening the way for future novel biological strategies that target tsetse's lactation cycle and associated reproductive capacity [26]. In addition, lactation-specific aquaporin proteins were also identified and are needed for water transport and hydration during milk synthesis [27]. Finally, comparison of before and after pregnancy transcriptomes indicates that prevention of oxidative stress may be the key for the success of the prolonged reproductive output and longevity associated with tsetse female physiology [28].

Tsetse carries with it multiple symbiotic microbes, one of which is called Wolbachia. Wolbachia has been shown to manipulate host reproductive physiology in many insects, including in tsetse [29]. One of the research papers in the collection describes the Whole Genome Sequence of the Wolbachia symbiont obtained from the same Glossina morsitans species [30]. This study also reports that unusually large sections of the genome of the Wolbachia symbiont have been transferred to the host tsetse genome, particularly residing in the sex chromosomes [30].

Finally, although extensive research has been conducted on African trypanosomes in the mammalian host, knowledge of tsetse–parasite interactions remains sparse. An area of interest has been discovery of tsetse mechanisms that can block parasite transmission either in the midgut or in the salivary glands. This is of interest to both basic and applied research since the ability to engineer greater resistance in flies could solve the problem of disease transmission. Researchers characterized important tsetse genes whose products are components of physical and immunological barriers in the gut Peritrophic Matrix (PM) to trypanosome infections [31]. Another study has compared trypanosome and tsetse transcriptomes from normal and parasitized salivary glands, as well as from normal and parasitized mammalian blood [32]. This study reports on parasite adaptations that may enable its survival in the two different host environments and host gene expression modifications that may help parasite survival in either the salivary gland or, possibly, in the mammalian bite site [32].

The wealth of information that is revealed from the genome and functional genomics data is now ready to be explored and exploited. The soon-to-be-available additional Glossina genomes will shed light onto the species-specific habitat and vertebrate host requirements and varying vector competence associated with the different species. Thus, money was well spent on the small investment made by WHO-TDR to bring together IGGI. An important goal of the genome project was expansion of the community of tsetse researchers—the consortium now invites all interested researchers, particularly junior scientists, to take a look at research opportunities on tsetse and trypanosomes. The consortium hopes that while HAT is a neglected tropical disease, vector tsetse research may enjoy broader participation from the vector community and lead to improved and/or novel methods to eliminate disease.